35 /100
MEDIUM RISK
Score updated Apr 29, 2026

ITRMF

Iterum Therapeutics plc — Stock Dilution Tracker

Track ITRMF dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track ITRMF — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
20
💰 Cash Runway
65
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
37%
🔄 Reverse Split 65%
• 50-day avg $0.13 below $1 exchange minimum
• 10 months cash with weak price
💰 Capital Raise 15%
• Under 12 months cash (10mo)
🔔 Track ITRMF — Get forecast alerts →
💹 Market Data
Market Cap$799.4K
Shares Outstanding53.29M
Float52.37M
Cash$11.00M
Debt$33.73M
Short InterestN/A
🏛 Institutional Holdings
5.2% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track ITRMF for full holder detail →
📉 Short Interest
Short Interest1.72M
Days to Cover1.0
% of Float3.3%
FINRA data as of Apr 15, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
Track ITRMF Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ITRMF — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for ITRMF
📊 ITRMF FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ITRMF Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.